No life sciences for ABN AMRO
ABN AMRO Capital Life Sciences has completed its spin-out from the Dutch private equity captive, raising €200m in its new independent guise as Forbion Capital Partners.
1 February 2007•2 mins read
ABN AMRO Capital Life Sciences has completed its spin-out from the Dutch private equity captive, raising €200m in its new independent guise as Forbion Capital Partners.